Investment Rating - The investment rating for the company is "Buy" (maintained) with a target price of RMB 6.95 and HKD 5.30 [6]. Core Insights - The company reported a revenue of RMB 182.26 billion for 2025, a year-on-year increase of 4.6%, and achieved a net profit attributable to shareholders of RMB 857 million, recovering from a net loss of RMB 1.696 billion in 2024 [1][4]. - The fourth quarter of 2025 saw a revenue of RMB 44.59 billion, up 12.7% year-on-year, with a net loss of RMB 1.45 billion, which was a 60.4% reduction in losses compared to the previous year [1][3]. - The company is expected to face challenges due to rising fuel costs influenced by geopolitical tensions, particularly in the Middle East, which may impact profitability despite a generally improving industry outlook [1][4]. Summary by Sections Financial Performance - The company achieved a gross margin improvement of 3.5 percentage points to 5.3% in Q4 2025, with a gross profit increase of RMB 1.643 billion year-on-year [3]. - The operating costs for Q4 2025 were RMB 42.22 billion, a year-on-year increase of 8.7%, while the unit cost per available ton-kilometer (ATK) decreased by 1.5% [3][4]. Operational Metrics - The company’s passenger load factor (PLF) increased by 1.4 percentage points to 85.7% for the year, while the unit revenue per passenger kilometer decreased by 4.2% [4][24]. - In Q4 2025, the available seat kilometers (ASK) increased by 9.8%, with international routes showing a significant growth of 19.3% [2][4]. Future Outlook - The company anticipates a stabilization of oil prices in the medium term, with industry supply growth expected to remain low, suggesting a potential upward trend in industry conditions [1][4]. - Profit forecasts for 2026 and 2027 have been revised downwards to net losses of RMB 2.376 billion and a profit of RMB 5.985 billion, respectively, primarily due to rising fuel costs [5][24].

Investment Rating - The investment rating for the company is maintained as "Buy" with a target price of RMB 66.00 [2]. Core Views - The report expresses a positive outlook on the company as a leading platform in specialty materials, anticipating a return to stable growth despite recent performance being below expectations due to delays in military product demand [6][10]. - The company is expected to benefit from international market expansion and internal integration, which will provide new growth momentum [7][8]. Financial Performance Summary - For the fiscal year 2025, the company achieved revenue of RMB 2,858 million, a year-over-year decrease of 2.52%, and a net profit attributable to the parent company of RMB 536.20 million, down 7.72% year-over-year [5][6]. - The fourth quarter of 2025 saw revenue of RMB 819 million, reflecting an 11.23% year-over-year increase and a 20.61% quarter-over-quarter increase [6]. - The company’s revenue from basic materials decreased by 7.70% to RMB 1,125 million, while revenue from aviation finished products increased by 6.84% to RMB 1,443 million [7]. Revenue and Profit Forecast - Revenue projections for 2026, 2027, and 2028 are RMB 3,130 million, RMB 3,537 million, and RMB 4,032 million, respectively, with expected growth rates of 9.51%, 13.01%, and 13.99% [5][10]. - The net profit attributable to the parent company is forecasted to be RMB 593.56 million in 2026, RMB 684.08 million in 2027, and RMB 789.62 million in 2028, with growth rates of 10.70%, 15.25%, and 15.43% respectively [5][10]. Valuation Metrics - The report provides a projected PE ratio of 44.81 for 2026, decreasing to 33.68 by 2028, and a PB ratio of 2.44 for 2026, decreasing to 2.19 by 2028 [5][10]. - The target price of RMB 66.00 corresponds to a PE of 50 for 2026, reflecting the company's strong technical advantages and resource backing [10].

Investment Rating - The investment rating for the company is "Buy" and is maintained for both A-shares and H-shares [6]. Core Views - The company reported a revenue of 308.23 billion RMB for 2025, representing a year-on-year increase of 8.37%, and a net profit attributable to shareholders of 11.12 billion RMB, up 9.31% year-on-year [1]. - The fourth quarter of 2025 saw a net profit of 2.81 billion RMB, exceeding expectations due to improved parcel volume structure and increased gross profit [1]. - The outlook remains positive, driven by the express logistics business, supply chain, and international operations, which are expected to expand further [1][4]. Summary by Relevant Sections Financial Performance - In 2025, the company achieved a total revenue of 308.23 billion RMB, with a net profit of 11.12 billion RMB and a non-recurring net profit of 9.26 billion RMB [1]. - The revenue from express logistics was 131.05 billion RMB, accounting for 41% of total revenue, with a year-on-year growth of 7.2% [2]. - The economic express segment saw a revenue increase of 17.6% to 32.05 billion RMB, driven by a significant rise in parcel volume [2]. Business Segments - The express logistics business generated 2,285.6 billion RMB in revenue, growing 11.1% year-on-year, while the combined revenue from freight, same-city delivery, cold chain, and pharmaceuticals reached 654.6 billion RMB, up 16.2% [3]. - The supply chain and international business revenue grew by 3.5% to 729.4 billion RMB, with a notable improvement in profitability [4]. Shareholder Returns - The company has committed to increasing its cash dividend payout ratio from 35% in 2023, with a planned buyback of shares amounting to 30-60 billion RMB for A-shares and 500 million HKD for H-shares [4]. - The total shareholder return, including dividends and buybacks, is projected to be 55% of net profit, translating to a dividend yield of approximately 3.3% for A-shares and 4.1% for H-shares [4]. Profit Forecast and Valuation - The forecast for net profit attributable to shareholders is adjusted downwards for 2026 and 2027 to 12.01 billion RMB and 13.30 billion RMB, respectively, with a new estimate for 2028 at 14.88 billion RMB [5]. - The company is valued at 8.2x EV/EBITDA for A-shares and 6.8x for H-shares, reflecting a premium over comparable companies [5].

Macro Insights - The Middle East conflict has raised global inflation expectations, with March PMI indicators for the US, Europe, and Japan showing weakness due to energy supply shocks and high oil prices impacting the real economy [2][3] - The US stock indices fell throughout the month, while oil prices surged significantly, leading to increased volatility in equity and commodity markets [2] - Domestic manufacturing capacity adjustments are nearing completion, and raw material prices have risen sharply due to oil supply shocks, potentially squeezing profits for mid- and downstream enterprises [3] Company-Specific Insights - Guizhou Moutai (600519 CH) is undergoing a critical year of market-oriented governance transformation, with short-term price stability for its flagship product and long-term growth potential [7] - China Duty Free Group (601888 CH) reported a revenue of 53.694 billion yuan, down 4.92% year-on-year, but showed signs of recovery in Q4 with a revenue increase of 2.81% [8] - RuiPu Bio (300119 CH) achieved a revenue of 3.398 billion yuan in 2025, reflecting a 10.7% year-on-year growth, with a focus on the development of its microbial protein project [10] - MingNing (1768 HK) reported a revenue increase of 68.2% to 66.17 billion yuan, driven by higher store openings and improved profitability [11] - Torch Electronics (603678 CH) achieved a revenue of 4.121 billion yuan, up 47.09% year-on-year, with a focus on diversifying its business to enhance competitiveness [13] - China Overseas Development (688 HK) reported a revenue of 168.1 billion yuan, down 9% year-on-year, but maintains a strong competitive advantage in the industry [14] - Poly Property (6049 HK) achieved a revenue of 17.13 billion yuan, up 5% year-on-year, with expectations for continued stable growth in 2026 [24] - Times Electric (688187 CH) reported a revenue of 28.703 billion yuan, up 15.23% year-on-year, with strong performance in its non-rail business segments [25]

Investment Rating - The report maintains a "Buy" rating for the company [8] Core Views - The company is expected to achieve a revenue of 28.5 billion RMB in 2025, representing a year-on-year increase of 34%, and a net profit attributable to shareholders of 9.8 billion RMB, up 72% year-on-year, exceeding previous expectations [1][2] - The company's strong performance is driven by robust growth in investment, brokerage, and investment banking businesses, with a notable quarterly net profit of 3.2 billion RMB in Q4 2025, reflecting a 14% year-on-year increase and a 44% quarter-on-quarter increase [1][2] - The company is benefiting from a recovery in capital market activity, with an attractive current valuation [1] Financial Performance - The net profit attributable to shareholders for the year reached 9.8 billion RMB, a significant improvement of 72% year-on-year, while total assets grew to 782.8 billion RMB, up 16% year-on-year [2] - The leverage ratio at year-end was 5.35x, an increase of 0.37x from the beginning of the year, indicating a more aggressive use of leverage throughout the year [2] - Financial investments were the main driver of asset expansion, with a year-end financial investment scale of 426.7 billion RMB, up 15% year-on-year [2] Business Segments - Investment business revenue reached 14.2 billion RMB, a 40% increase year-on-year, making it the largest revenue source for the company [4] - Investment banking revenue was 5 billion RMB, up 63% year-on-year, with Q4 2025 showing a remarkable 103% year-on-year increase [4] - Brokerage business revenue increased by 45% year-on-year to 6.2 billion RMB, benefiting from heightened market activity [4] International Business - The company's international business showed strong performance, with total assets of 238.3 billion RMB, accounting for 30% of the group's total assets [5] - International business revenue reached 8.4 billion RMB, a 58% year-on-year increase, contributing 29% to total revenue [5] Profit Forecast and Valuation - The company expects net profits of 11.4 billion RMB, 13 billion RMB, and 14.3 billion RMB for 2026, 2027, and 2028 respectively, with significant upward adjustments of 28% for 2026 and 2027 [6] - The target price is set at 43.60 RMB and 24.69 HKD, reflecting a premium valuation based on the company's strong growth and competitive international business [6]

Investment Rating - The report maintains a "Buy" rating for the company with a target price of HKD 61.50 [6]. Core Insights - The company reported total revenue of RMB 107.34 billion for 2H25, a year-on-year increase of 26.3%, and an annual revenue of RMB 201.90 billion, up 37.7%, slightly below expectations by 2% [1]. - Core ride-hailing service revenue reached RMB 99.64 billion, growing 27.3% year-on-year, driven by a significant increase in monthly active users (MAU) and active drivers [2][3]. - The adjusted net loss for 2H25 was RMB -1.79 billion, with an annual adjusted net loss of RMB -5.08 billion, narrowing by 29.8%, exceeding expectations by 10% [2]. Revenue Growth - The core ride-hailing service revenue of RMB 99.64 billion was primarily driven by a 43.9% year-on-year increase in MAU and a 35.4% increase in average monthly active drivers [2]. - The Gross Transaction Value (GTV) for 2H25 reached RMB 124.73 billion, reflecting a year-on-year growth of 27.0% [3]. User Expansion and Market Penetration - The company has expanded its services to 195 cities, adding 59 new cities, which has improved supply-demand matching efficiency in tier-3 and tier-4 markets [3]. - The increase in user MAU and active drivers indicates enhanced penetration and user stickiness across the country [3]. Robotaxi Strategy - The company is advancing its Robotaxi strategy, having launched the Caocao Smart Mobility platform and deployed Robotaxi pilot programs in early 2025, with plans for mass production by 2027 [4]. - The company aims to expand its Robotaxi operations internationally, with plans for initial operations in Abu Dhabi and Hong Kong [4]. Financial Projections - Revenue projections for 2026, 2027, and 2028 are RMB 262 billion, RMB 324 billion, and RMB 394 billion, respectively, with adjusted net profits expected to be RMB 0.5 billion, RMB 5.3 billion, and RMB 13.6 billion [5][11]. - The report anticipates a continued narrowing of losses through operational efficiency and algorithm optimization [2][11].

Investment Rating - The investment rating for Hisense Home Appliances is maintained at "Buy" [7] Core Views - The company reported a revenue of RMB 87.93 billion for 2025, a decrease of 5.19% year-on-year, and a net profit attributable to shareholders of RMB 3.19 billion, down 4.82% year-on-year. The decline in total revenue was primarily due to a significant drop in other business income [1] - Despite the overall revenue and profit pressure, the core business showed resilience, with cash flow from operating activities improving by 12.94% year-on-year [1] - The company continues to pay dividends, distributing RMB 12.65 per 10 shares [1] Summary by Sections HVAC Business - The HVAC segment remains the largest revenue source, generating RMB 38.83 billion in 2025, down 3.61% year-on-year, with a gross margin of 27.43%, a decrease of 1.12 percentage points [2] - The company holds over 23% market share in the domestic multi-split air conditioning market, maintaining industry leadership despite weak real estate and public construction projects [2] - Domestic sales of household air conditioners increased by 9.6%, outperforming the industry growth rate by 8.9 percentage points [2] Refrigeration and Washing Business - The refrigeration and washing segment achieved revenue of RMB 31.20 billion in 2025, an increase of 1.16% year-on-year, with a gross margin of 17.63%, up 0.07 percentage points [3] - The company is focusing on product upgrades in health preservation and vacuum preservation, with market share in refrigerator retail rising to 17.0% [3] - The washing machine segment has seen rapid growth in global revenue, supported by new product launches [3] Profitability - The overall gross margin for the company in 2025 was approximately 21.3%, an increase of 0.53 percentage points, driven by a faster decline in costs compared to revenue [4] - The total expense ratio increased by 0.65 percentage points, primarily due to a rise in financial expenses [4] Future Outlook - EPS forecasts for 2026 and 2027 have been adjusted to RMB 2.66 and RMB 2.94, respectively, reflecting a downward revision of 8.3% and 9.7% [5] - The target price for A-shares is set at RMB 26.60, based on a 10x PE ratio for 2026 [5]

Investment Rating - The report maintains a "Buy" rating for the company [7] Core Views - The company reported a revenue of 15.028 billion RMB (+22.6% YoY) and a net profit of 5.555 billion RMB (+27.1% YoY) for the year 2025, with innovative drugs contributing 12.354 billion RMB (+30.4% YoY), accounting for 82.2% of total revenue [1][7] - The growth is driven by both innovation and business development (BD), indicating a strong outlook for continued growth [1] Revenue Breakdown - Oncology segment revenue reached 9.974 billion RMB (+23% YoY), primarily due to the strong performance of core products like Amivantamab and milestone income from GSK [2] - Anti-infection revenue was 1.586 billion RMB (+8% YoY), driven by the sales of Adefovir [2] - CNS segment revenue was 1.310 billion RMB (-5% YoY), with the negative impact from centralized procurement on generic drugs largely mitigated [2] - Revenue from metabolic and other diseases surged to 2.158 billion RMB (+67% YoY), mainly due to milestone payments from Merck [2] R&D Progress - The company has 8+1 innovative drugs and 15+3 indications approved, with 40+ molecules in over 70 clinical trials [3] - Key pipelines include Amivantamab, HS-20093, HS-20089, HS-20094, and HS-20117, with several in Phase III clinical trials [3] International Collaboration - The company has achieved at least one high-quality external authorization each year for the past three years, accumulating 542 million USD in upfront payments and a total of 8.8 billion USD in potential revenue from five projects in Europe and the US [4] - Ongoing collaborations with GSK, Regeneron, and MSD are progressing positively, with several projects in various clinical stages [4] Profit Forecast and Valuation - The company’s net profit forecasts for 2026 and 2027 have been raised to 6.228 billion RMB and 6.602 billion RMB, respectively, reflecting an increase of 14% and 15% [5] - The target price is set at 43.68 HKD, based on a sum-of-the-parts (SOTP) valuation of 264.5 billion HKD [5]

Investment Rating - The report maintains a "Buy" rating for the company with a target price of 17.43 RMB, up from a previous value of 13.5 RMB, corresponding to a 90 times PE for 2026 [7]. Core Insights - The company reported a revenue of 3.65 billion RMB for 2025, a year-on-year decrease of 18.43%, with a net loss attributable to the parent company of 40.58 million RMB. However, Q4 showed a revenue increase of 16.92% year-on-year and a net profit of 41.05 million RMB, indicating a recovery in profitability and improved cost management [1]. - The gross margin for Q4 improved to 18.07%, up 12.27 percentage points year-on-year, primarily due to the recovery in the gross margin of the slicing outsourcing business [2]. - The company has effectively controlled its expense ratio, achieving a net profit margin of 3.37% in Q4, reflecting improved operational efficiency despite a contraction in revenue [3]. - The company is transitioning from a single equipment exporter to a global comprehensive service provider, with a focus on equipment delivery, technical services, and silicon wafer cutting outsourcing [4]. - Profit forecasts for 2026 and 2027 have been raised to 176.2 million RMB and 213.1 million RMB, respectively, driven by expected growth in overseas equipment sales and steady growth in outsourcing business [5]. Summary by Sections Financial Performance - For 2025, the company achieved a revenue of 3.65 billion RMB, with a net loss of 40.58 million RMB. Q4 revenue was 1.22 billion RMB, showing a quarter-on-quarter increase of 24.46% [1]. - The overall gross margin for the year was 14.35%, down 4.63 percentage points year-on-year, while Q4 gross margin was 18.07%, reflecting a recovery [2]. Expense Management - The company maintained a net profit margin of -1.11% for the year, with a significant improvement in Q4 to 3.37%. The total expense ratio decreased to 16.59%, down 1.3 percentage points year-on-year [3]. Business Development - The company is expanding its slicing outsourcing capacity, with a total planned capacity of 102 GW, of which 70 GW has been implemented. This expansion is expected to gradually restore gross margins [2][4]. - The company is also developing humanoid robots and has received orders for related components, indicating diversification into new growth areas [4]. Valuation and Forecast - The company’s net profit forecasts for 2026 and 2027 have been adjusted upwards to 176.2 million RMB and 213.1 million RMB, respectively, with a new forecast for 2028 at 344 million RMB [5].

Investment Rating - The report maintains a "Buy" rating for the company with a target price of RMB 220.70 [7]. Core Insights - The company achieved a revenue of RMB 2.142 billion in 2025, representing a year-over-year increase of 75.65%, and a net profit of RMB 173 million, up 187.72% year-over-year [1][2]. - The growth is attributed to the recovery in downstream demand and effective cost control, with significant contributions from the power management and signal chain segments [2][3]. - The company is well-positioned in the industrial and automotive markets, with a strong product lineup and a growing customer base [4]. Summary by Sections Financial Performance - In 2025, the company reported a revenue of RMB 2.142 billion, with a gross margin of 47.1% and a net profit margin of 7.7% [2]. - The revenue from power management products reached RMB 730 million, accounting for 34% of total revenue, while signal chain products generated RMB 1.41 billion, making up 65.8% of total revenue [2]. - The company’s net profit for 2025 was RMB 173 million, marking a significant turnaround from previous losses [2]. Market Position and Product Development - The company has launched over 3,200 products, focusing on the dual drivers of signal chain and power management [3]. - Key new products include high-performance amplifiers and various automotive-grade chips, with significant sales in the automotive sector exceeding RMB 300 million in 2025 [4]. - The integration of acquired company Chuangxinwei has led to rapid growth in sales of lithium battery protection and MOSFET products, contributing RMB 379 million to revenue in 2025 [3]. Future Outlook - The company expects continued growth in 2026, with projected revenues of RMB 2.82 billion, reflecting a year-over-year increase of 31.54% [5]. - The forecast for net profit in 2026 is RMB 338 million, with a projected decline in profit margins due to rising upstream costs [5]. - The company is anticipated to benefit from the ongoing recovery in the industrial and automotive sectors, as well as the increasing demand for its products in communication and consumer electronics [1][4].